Charlotte M. Proby

11.6k total citations
159 papers, 6.8k citations indexed

About

Charlotte M. Proby is a scholar working on Epidemiology, Oncology and Dermatology. According to data from OpenAlex, Charlotte M. Proby has authored 159 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Epidemiology, 75 papers in Oncology and 68 papers in Dermatology. Recurrent topics in Charlotte M. Proby's work include Nonmelanoma Skin Cancer Studies (85 papers), Cutaneous Melanoma Detection and Management (35 papers) and Cancer and Skin Lesions (34 papers). Charlotte M. Proby is often cited by papers focused on Nonmelanoma Skin Cancer Studies (85 papers), Cutaneous Melanoma Detection and Management (35 papers) and Cancer and Skin Lesions (34 papers). Charlotte M. Proby collaborates with scholars based in United Kingdom, United States and Netherlands. Charlotte M. Proby's co-authors include Catherine Harwood, Irene M. Leigh, Judith Breuer, Karin J. Purdie, Jane McGregor, T. Surentheran, R. Cerio, J.M. McGregor, Jan Nico Bouwes Bavinck and Sylvie Euvrard and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Charlotte M. Proby

155 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotte M. Proby United Kingdom 50 4.2k 2.8k 2.5k 1.5k 843 159 6.8k
Catherine Harwood United Kingdom 49 4.8k 1.1× 4.2k 1.5× 2.5k 1.0× 2.4k 1.6× 854 1.0× 183 8.6k
Sylvie Euvrard France 36 3.5k 0.8× 3.1k 1.1× 1.9k 0.8× 535 0.3× 511 0.6× 127 5.3k
Alan Storey United Kingdom 36 2.4k 0.6× 1.8k 0.6× 394 0.2× 1.6k 1.0× 613 0.7× 74 4.5k
Henry G. Skelton United States 35 1.3k 0.3× 1.1k 0.4× 1.4k 0.5× 692 0.4× 354 0.4× 163 3.8k
H. Kerl Austria 34 1.8k 0.4× 2.0k 0.7× 2.8k 1.1× 544 0.4× 763 0.9× 162 4.9k
Gary S. Wood United States 53 2.2k 0.5× 2.3k 0.8× 5.0k 2.0× 1.5k 0.9× 3.3k 3.9× 174 9.7k
Stefania Jabłońska Poland 55 3.3k 0.8× 1.1k 0.4× 2.2k 0.9× 1.2k 0.8× 1.7k 2.0× 261 8.9k
Rachael A. Clark United States 43 1.2k 0.3× 1.6k 0.6× 2.5k 1.0× 927 0.6× 5.8k 6.9× 111 8.3k
Nicola Pimpinelli Italy 37 2.1k 0.5× 1.4k 0.5× 3.8k 1.5× 700 0.5× 1.6k 1.9× 204 6.0k
E Grosshans France 36 1.3k 0.3× 785 0.3× 2.0k 0.8× 991 0.6× 675 0.8× 303 4.8k

Countries citing papers authored by Charlotte M. Proby

Since Specialization
Citations

This map shows the geographic impact of Charlotte M. Proby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte M. Proby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte M. Proby more than expected).

Fields of papers citing papers by Charlotte M. Proby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte M. Proby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte M. Proby. The network helps show where Charlotte M. Proby may publish in the future.

Co-authorship network of co-authors of Charlotte M. Proby

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte M. Proby. A scholar is included among the top collaborators of Charlotte M. Proby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte M. Proby. Charlotte M. Proby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murchie, Peter, Lynda Constable, Susan J. Hall, et al.. (2022). The Achieving Self-directed Integrated Cancer Aftercare Intervention for Detection of Recurrent and Second Primary Melanoma in Survivors of Melanoma: Pilot Randomized Controlled Trial. JMIR Cancer. 8(3). e37539–e37539. 5 indexed citations
2.
Keohane, Stephen, P.G. Budny, O.M. Dolan, et al.. (2020). British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020*. British Journal of Dermatology. 184(3). 401–414. 56 indexed citations
3.
4.
Venables, Zoe C, Tamar Nijsten, Kwok Wong, et al.. (2019). Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013–15: a cohort study. British Journal of Dermatology. 181(3). 474–482. 102 indexed citations
5.
Purdie, Karin J., Jun Wang, Catherine Harwood, et al.. (2019). A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing. International Journal of Molecular Sciences. 20(14). 3428–3428. 19 indexed citations
6.
McHugh, Angela, Kenneth Fernandes, Adel F.M. Ibrahim, et al.. (2019). The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 140(6). 1154–1165.e5. 12 indexed citations
7.
8.
Harkins, Catriona P., Maeve A. McAleer, Désirée E. Bennett, et al.. (2018). The widespread use of topical antimicrobials enriches for resistance inStaphylococcus aureusisolated from patients with atopic dermatitis. British Journal of Dermatology. 179(4). 951–958. 39 indexed citations
9.
Lai, Kevin, Catherine Harwood, Karin J. Purdie, et al.. (2017). Genomic analysis of atypical fibroxanthoma. PLoS ONE. 12(11). e0188272–e0188272. 29 indexed citations
10.
Knatko, Elena V., Sally H. Ibbotson, Ying Zhang, et al.. (2015). Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans. Cancer Prevention Research. 8(6). 475–486. 95 indexed citations
11.
Neale, Rachel Ε., Soenke J. Weissenborn, Damiano Abeni, et al.. (2013). Human Papillomavirus Load in Eyebrow Hair Follicles and Risk of Cutaneous Squamous Cell Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 22(4). 719–727. 78 indexed citations
12.
Harden, Paul, Andries J. Hoitsma, Charlotte M. Proby, et al.. (2013). Two-Year Randomized Controlled Prospective Trial Converting Treatment of Stable Renal Transplant Recipients With Cutaneous Invasive Squamous Cell Carcinomas to Sirolimus. Journal of Clinical Oncology. 31(10). 1317–1323. 101 indexed citations
13.
Harwood, Catherine, David Mesher, J.M. McGregor, et al.. (2012). A Surveillance Model for Skin Cancer in Organ Transplant Recipients: A 22-Year Prospective Study in an Ethnically Diverse Population. American Journal of Transplantation. 13(1). 119–129. 94 indexed citations
14.
Fijter, Johan W. de, Paul Harden, A. J. Hoitsma, et al.. (2012). Reduced Cutaneous Squamous Cell Carcinoma after Conversion to Sirolimus: A 2-Year Prospective Open-Label Multicenter Trial. American Journal of Transplantation. 12. 161–161. 2 indexed citations
15.
Lambert, S., Catherine Harwood, Karin J. Purdie, et al.. (2011). Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene. International Journal of Cancer. 131(3). E216–26. 14 indexed citations
16.
Proby, Charlotte M., Catherine Harwood, Rachel Ε. Neale, et al.. (2011). A Case–Control Study of Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. American Journal of Transplantation. 11(7). 1498–1508. 98 indexed citations
17.
Harwood, Catherine & Charlotte M. Proby. (2002). Human papillomaviruses and non-melanoma skin cancer. Current Opinion in Infectious Diseases. 15(2). 101–114. 125 indexed citations
18.
Harwood, Catherine, T. Surentheran, Jane McGregor, et al.. (2000). Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. Journal of Medical Virology. 61(3). 289–297. 334 indexed citations
19.
Proby, Charlotte M., et al.. (1999). Human Autoantibodies against HD1/Plectin in Paraneoplastic Pemphigus. Journal of Investigative Dermatology. 112(2). 153–156. 51 indexed citations
20.
Proby, Charlotte M., Hélène du P. Menagé, Jane McGregor, et al.. (1993). p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non‐melanoma skin neoplasms. Journal of Cutaneous Pathology. 20(5). 435–441. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Harwood Breakdown of academic impact, for papers by Sylvie Euvrard Breakdown of academic impact, for papers by Alan Storey Breakdown of academic impact, for papers by Henry G. Skelton Breakdown of academic impact, for papers by H. Kerl Breakdown of academic impact, for papers by Gary S. Wood Breakdown of academic impact, for papers by Stefania Jabłońska Breakdown of academic impact, for papers by Rachael A. Clark Breakdown of academic impact, for papers by Nicola Pimpinelli Breakdown of academic impact, for papers by E Grosshans
Rankless by CCL
2026